共 50 条
- [21] Efficacy and safety of rotigotine transdermal patch in Chinese patients with early-stage Parkinson's disease: A randomized, double-blind, placebo-controlled studyMOVEMENT DISORDERS, 2015, 30 : S137 - S138Zhang, Z.Asgharnejad, M.Du, X.Surmann, E.Bauer, L.
- [22] Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: A prospective, open-label extension studyPARKINSONISM & RELATED DISORDERS, 2012, 18 (05) : 488 - 493Elmer, Lawrence W.Surmann, ErwinBoroojerdi, BabakJankovic, Joseph
- [23] Long-term safety of rotigotine transdermal patch in early-stage Parkinson's disease: Results from 4 yearsMOVEMENT DISORDERS, 2009, 24 : S286 - S286Watts, R.Pahwa, R.Lyons, K.Boroojerdi, B.
- [24] Stable rotigotine plasma concentrations over 24 hours in patients with early-stage Parkinson's disease after once-daily transdermal administration of rotigotine (Neupro®)NEUROLOGY, 2006, 66 (05) : 293 - 293Elshoff, JPCawello, WBraun, MHorstmann, R
- [25] Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson's diseasePARKINSONISM & RELATED DISORDERS, 2014, 20 (12) : 1345 - 1351Giladi, NirGhys, LiesbetSurmann, ErwinBoroojerdi, BabakJankovic, Joseph
- [26] Non-interventional study to assess the compliance with rotigotine transdermal system in a sample of idiopathic early-stage Parkinson's disease subjectsJOURNAL OF NEURAL TRANSMISSION, 2009, 116 (02) : 235 - 235Schnitzler, A.Leffers, K. W.Haeck, H. J.Randerath, O.
- [27] Efficacy of the rotigotine transdermal patch in patients with early-stage, idiopathic Parkinson's disease. Results of a multicenter, multinational, randomized, double-blind, placebo-controlled trialEUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 9 - 10Watts, R. L.Wendt, J.Nausieda, P. L.Boroojerdi, B.Poole, K. H.Sommerville, K. W.
- [28] Steady-state pharmacokinetics of rotigotine in patients with early-stage Parkinson's diseaseEUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 96 - 96Braun, M.Cawello, W.Poole, K.Horstmann, R.
- [29] Treatment of patients with early and advanced Parkinson's disease with transdermal rotigotine: safety and tolerability in elderly patientsPARKINSONISM & RELATED DISORDERS, 2009, 15 : S129 - S129Oertel, W.LeWitt, P.Watts, R.Grieger, F.Bauer, L.Boroojerdi, B.
- [30] Safety and efficacy of transdermal rotigotine for the treatment of fatigue and quality of life (QOL) in patients with Parkinson's diseaseMOVEMENT DISORDERS, 2015, 30 : S148 - S149Abe, K.Kitamura, S.Yokoa, I.Ogura, J.Fjita, M.Yoshikawa, H.